... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
oxygen molecular entity >
organooxygen compound >
carbonyl compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
heteroatomic molecular entity >
halide >
organohalogen compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
halogen molecular entity >
halide >
organohalogen compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organohalogen compound >
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
Preferred term
n-[(2s,4ar,12ar)-2-[2-[(1,3-dimethyl-4-pyrazolyl)amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-fluorobenzamide
inchi
-
InChI=1S/C28H30FN5O5/c1-16-22(14-33(2)32-16)31-26(35)13-20-8-9-23-25(39-20)15-38-24-10-7-19(12-21(24)28(37)34(23)3)30-27(36)17-5-4-6-18(29)11-17/h4-7,10-12,14,20,23,25H,8-9,13,15H2,1-3H3,(H,30,36)(H,31,35)/t20-,23+,25-/m0/s1
inchikey
-
LLFGMIFPADLUOD-ZWSUVBHBSA-N
smiles
-
CC1=NN(C=C1NC(=O)C[C@@H]2CC[C@@H]3[C@@H](O2)COC4=C(C=C(C=C4)NC(=O)C5=CC(=CC=C5)F)C(=O)N3C)C
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:98964